The FDA has warned that Invokana, Farxiga & Jardiance may be linked to the flesh-eating genital infection Fournier’s gangrene and other studies have suggested they may increase risks for bladder and kidney cancer.
Thousands have filed lawsuits against the maker of Invokana in Federal and State courts around the country and some cases have already been settled. Find out if you qualify for a claim and how much it may be worth.
Attorneys are still helping those affected by Invokana file claims. However, the time to take action is limited. Speak to a lawyer today to learn about your options and join the litigation. It costs nothing unless you win.
Invokana is a type 2 diabetes drug of the sodium-glucose transport-2 protein (SGLT2) inhibitor class.
These drugs, also known as gliflozins, work by blocking the kidneys’ ability to absorb most of the sugar in the blood, which is instead flushed out in urine.
Unfortunately, the FDA has warned of several dangerous Invokana diabetes side effects that weren’t disclosed by the manufacturer. These latest of these warnings is for Fournier's Gangrene, a severe flesh-eating bacterial infection that affects the genital areas.
Since the first Invokana lawsuit was filed in 2015, more than 1,000 patients have joined the litigation against this diabetes drug, with many claims consolidated in special federal or state multidistrict courts.
Lawyers are now helping those diagnosed with genital gangrene, also known as Fournier's gangrene, as well as those diagnosed with bladder or kidney cancer. If you or a loved one have been affected by one of these diseases, you may be eligible for compensation. Contact us today to speak with a lawyer about your case.
The claims filed against Janssen Pharmaceuticals for Invokana injuries usually seek compensation for medical bills, lost wages, future expenses, pain and suffering. Depending on the degree of injury or loss, claims can range from less than $50,000 to more than $1 million.
Since every case is unique, it is difficult to predict the value without a complete review of medical records and gathering facts from the injured party.
For this reason, it is recommended that patients who suffered complications while taking Invokana speak with a lawyer to determine if they qualify for a case and what it may be worth.
Fortunately, it costs nothing to file a claim, and the injured patient is only responsible for attorney’s fees and costs if they receive an award in their case.
On August 29, 2018, the FDA warned that the SGLT2 class of diabetes drugs including Invokana, Farxiga and Jardiance may be linked to a rare but serious flesh-eating genital infection called Fournier's gangrene.
Fournier's gangrene can affect skin, muscle, nerves, fat, blood vessels and other soft tissue around the genital area.
Usually, the disease affects males between the ages of 50 and 80. However, the FDA noted 12 men and women who were hospitalized from Fournier’s soon after starting Invokana, Farxiga or Jardiance. In comparison, only 6 cases of Fournier's gangrene have been linked to other diabetes drugs in the past 30 years.
Some of the common symptoms of Fournier's gangrene include:
Fournier's gangrene is usually treated with strong antibiotics, surgery to remove dead tissue, or with experimental hyperbaric oxygen therapy. On average, patients require 3-4 surgeries and many lose their genital organs. It has also been linked to death.
On December 7, 2016, the Judicial Panel on Multidistrict Litigation entered an order consolidating more than 100 similar Invokana lawsuits to Multidistrict Litigation (MDL) 2750, under the direction of U.S. District Judge Brian Martinotti in the District of New Jersey.
The case is formally known as In RE: Invokana (Canagliflozin) Products Liability Litigation. While this MDL court is similar to an Invokana class action lawsuit, it differs slightly in that the cases are filed and maintained separately, giving each plaintiff more control over major case decisions and who will represent them.
As of January 2018, 1,004 claims have been filed or transferred to the Invokana MDL, representing a variety of injuries. Trials are expected to begin in the fall of 2018 with the selection of a handful of Bellwether test cases that will set the tone for future trials or settlement negotiations.
Those affected may still file a claim to join the Invokana Class Action Lawsuit MDL. However, time is limited. Contact us today to speak with a lawyer at no cost about your options.
Latest news on Invokana.
It is important to speak with a lawyer if you or a loved one suffered genital gangrene or Fournier's gangrene after taking Invokana. However, choosing the right one can have a significant impact on your case.
First, drug injury lawsuits are often consolidated to special nationwide MDL courts along with thousands of similar cases. Therefore, the lawyer with the experience and specialization for your case may not be located in your city or even your state.
However, your lawyer will come meet you in person if necessary, then handle all aspects of your case for you. Therefore, it is likely you won’t have to leave your home.
Your Invokana lawyer should also have a detailed understanding of clinical trials and side effect research, as well as access to the experts that perform these reviews.
Finally, your lawyer must have the experience of fighting claims against large and formidable opponents like multinational drug companies, as well as the resources to complete your case.
DrugNews works only with law firms that have handled hundreds of Invokana lawsuits. Contact us to speak with your lawyer today.
Details about filing a claim.
It's important to speak with a lawyer if you or a loved one suffered amputation, ketoacidosis or kidney injury after taking Invokana. However, choosing the right one can have a significant impact on your case.
First, drug injury lawsuits are often consolidated to special nationwide MDL courts along with thousands of similar cases. Therefore, the lawyer with the experience and specialization for your case may not be located in your city or even your state.
However, your lawyer will come meet you in person if necessary, then handle all aspects of your case for you. Therefore, it is likely you won’t have to leave your home.
Your Invokana lawyer should also have a detailed understanding of clinical trials and side effect research, as well as access to the experts that perform these reviews.
Finally, your lawyer must have the experience of fighting claims against large and formidable opponents like multinational drug companies, as well as the resources to complete your case.
DrugNews works only with law firms that have handled hundreds of Invokana lawsuits. Contact us to speak with your lawyer today.
Have you seen an Invokana Lawsuit commercial and want to learn more about the risks of the drug, the litigation process, or whether you qualify? Our patient advocates are available 24 hours a day to provide more information and connect you with a lawyer.
Most Invokana lawsuit commercials mention recent FDA warnings for gangrene, ketoacidosis or amputations, as well as studies linking the drug to cancer. In addition, reports have linked the drug to blood clots, stroke, pancreatitis, infection and hair loss.
Overall, the FDA has received more than 6,000 reports of serious side effects among patients. In many cases, these were complications that were not disclosed by the manufacturer.
The first case against Invokana was filed in 2015 and the litigation has now grown to more than 1,000 cases in federal MDL courts. Invokana lawyers are still helping those affected file claims. Contact us today to learn more.
As the growing Invokana litigation enters its third year in 2018, experts believe the thousands of injured patients could finally see a resolution of their case.
The number of claims filed in the federal MDL court has eclipsed 1,000, and this doesn’t account for hundreds of other cases filed in state courts or being prepared for filing.
In the Invokana MDL 2750, Case Management Conferences have been scheduled every month to prepare for the first round of trials, which are set to begin in September.
With the pressure of highly-publicized trials, J&J could agree to settle many of the outstanding Invokana Lawsuits in 2018.
For now, there is still time left to file a claim. If you have questions about your Invokana injuries, or wish to speak with a lawyer, contact us today.
As Invokana lawsuits entered 2017, word began to spread of the drug’s risks and the opportunity for those injured to seek justice due to the creation of the federal MDL court.
As a result of the added publicity, more patients that had experienced severe side effects without knowing the reason learned of the connection with their diabetes medication.
The number of lawsuits grew substantially to more than 900 by the end of 2017, with claims added for stroke, blood clots, pancreatitis and other side effects.
Also, the EMA and FDA added formal boxed warnings to Invokana for increased amputation risks, after CANVAS study data showed patients could double their risks by taking the drug.
As litigation continued to grow, rumors emerged that Johnson & Johnson had begun trying to settle some of the cases before they reached a public trial.
2016 was an important year in the development of Invokana litigation. Beginning in January, the Institute for Safe Medication Practices reported on a troubling increase in the number of adverse event reports filed for Invokana with the FDA.
The FDA, having already warned patients of ketoacidosis risks, adds stronger warniings to Invokana for kidney damage, and also reports on new studies showing the drug may increase the risk of leg amputations.
Finally, that December, with more than 140 lawsuits already filed in courts around the country, the federal Judicial Panel on Multidistrict Litigation joins the cases into one centralized court for easier handling.
Call, email or live chat with us today to see how we can help.